Clinical Trials Logo

Extensive Stage Unresectable clinical trials

View clinical trials related to Extensive Stage Unresectable.

Filter by:
  • None
  • Page 1

NCT ID: NCT00264134 Terminated - Clinical trials for Non-small Cell Lung Cancer

Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer

Start date: June 2003
Phase: Phase 1/Phase 2
Study type: Interventional

Primary Objective: To determine the maximum tolerated dose of docetaxel when given with Irinotecan and Carboplatin for the treatment of inoperable lung cancer. Secondary Objective: To evaluate the dose-related toxicities of this triple regimen in patients with inoperable lung cancer.